231 related articles for article (PubMed ID: 30033649)
1. Effectiveness of Continuous Subcutaneous Insulin Infusion on Parental Quality of Life and Glycemic Control Among Children With T1D: Meta-Analysis.
Li AY; So WK; Leung DY
Worldviews Evid Based Nurs; 2018 Oct; 15(5):394-400. PubMed ID: 30033649
[TBL] [Abstract][Full Text] [Related]
2. Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(20):1-58. PubMed ID: 23074525
[TBL] [Abstract][Full Text] [Related]
3. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
[TBL] [Abstract][Full Text] [Related]
4. New insulin delivery devices and glycemic outcomes in young patients with type 1 diabetes: a protocol for a systematic review and meta-analysis.
Dos Santos TJ; Donado Campos JM; Fraga Medin CA; Argente J; Rodríguez-Artalejo F
Syst Rev; 2019 Nov; 8(1):259. PubMed ID: 31685014
[TBL] [Abstract][Full Text] [Related]
5. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.
Cummins E; Royle P; Snaith A; Greene A; Robertson L; McIntyre L; Waugh N
Health Technol Assess; 2010 Feb; 14(11):iii-iv, xi-xvi, 1-181. PubMed ID: 20223123
[TBL] [Abstract][Full Text] [Related]
6. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.
Golden SH; Sapir T
J Manag Care Pharm; 2012 Aug; 18(6 Suppl):S1-17. PubMed ID: 22984955
[TBL] [Abstract][Full Text] [Related]
7. Clinical Outcome and Cost-Effectiveness Analysis of CSII Versus MDI in Children and Adolescent With Type 1 Diabetes Mellitus in a Public Health Care System of China.
Hu S; Yang H; Chen Z; Leng X; Li C; Qiao L; Lv W; Li T
Front Endocrinol (Lausanne); 2021; 12():604028. PubMed ID: 33859614
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy outcome and glycemic control in women with type 1 diabetes: a retrospective comparison between CSII and MDI treatment.
Talaviya PA; Saboo BD; Joshi SR; Padhiyar JN; Chandarana HK; Shah SJ; Vyas CK; Shah AN
Diabetes Metab Syndr; 2013; 7(2):68-71. PubMed ID: 23680243
[TBL] [Abstract][Full Text] [Related]
9. Use of continuous subcutaneous insulin infusion versus multiple daily injections in emerging adults with type 1 diabetes is associated with better clinical engagement but not glycaemic control.
Chai TYL; Farrell K; Holmes-Walker DJ
Intern Med J; 2023 Feb; 53(2):255-261. PubMed ID: 34561942
[TBL] [Abstract][Full Text] [Related]
10. [Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes mellitus].
Hasselmann C; Bonnemaison E; Faure N; Mercat I; Bouillo Pépin-Donat M; Magontier N; Chantepie A; Labarthe F
Arch Pediatr; 2012 Jun; 19(6):593-8. PubMed ID: 22584198
[TBL] [Abstract][Full Text] [Related]
11. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C;
BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112
[TBL] [Abstract][Full Text] [Related]
12. Does the timing of insulin pump therapy initiation after type 1 diabetes onset have an impact on glycemic control?
Shalitin S; Lahav-Ritte T; Lebenthal Y; Devries L; Phillip M
Diabetes Technol Ther; 2012 May; 14(5):389-97. PubMed ID: 22283639
[TBL] [Abstract][Full Text] [Related]
13. Insulin pump therapy is associated with higher rates of mild diabetic ketoacidosis compared to injection therapy: A 2-year Swedish national survey of children and adolescents with type 1 diabetes.
Wersäll JH; Adolfsson P; Forsander G; Hanas R
Pediatr Diabetes; 2022 Nov; 23(7):1038-1044. PubMed ID: 35678764
[TBL] [Abstract][Full Text] [Related]
14. Continuous subcutaneous insulin infusion vs multiple daily injections in pregnant women with type 1 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials and observational studies.
Rys PM; Ludwig-Slomczynska AH; Cyganek K; Malecki MT
Eur J Endocrinol; 2018 May; 178(5):545-563. PubMed ID: 29545258
[TBL] [Abstract][Full Text] [Related]
15. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes.
Farrar D; Tuffnell DJ; West J; West HM
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD005542. PubMed ID: 27272351
[TBL] [Abstract][Full Text] [Related]
16. Quality of life in Danish children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion or multiple daily injections.
Birkebaek NH; Kristensen LJ; Mose AH; Thastum M;
Diabetes Res Clin Pract; 2014 Dec; 106(3):474-80. PubMed ID: 25451903
[TBL] [Abstract][Full Text] [Related]
17. Continuous Glucose Monitoring Use in Type 1 Diabetes: Longitudinal Analysis Demonstrates Meaningful Improvements in HbA1c and Reductions in Health Care Utilization.
Parkin CG; Graham C; Smolskis J
J Diabetes Sci Technol; 2017 May; 11(3):522-528. PubMed ID: 28745091
[TBL] [Abstract][Full Text] [Related]
18. MDI versus CSII in Chinese adults with type 1 diabetes in a real-world situation: based on propensity score matching method.
Yu J; Wang H; Zhu M; Xu J
Health Qual Life Outcomes; 2024 Jun; 22(1):47. PubMed ID: 38872219
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of continuous subcutaneous insulin infusion versus multiple daily insulin for treatment of children with type 1 diabetes.
Zhang L; Leng X; Tian F; Xiao D; Xuan J; Yang H; Liu J; Chen Z
Postgrad Med; 2022 Aug; 134(6):627-634. PubMed ID: 35695267
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
